More about

Leukemia

News
May 19, 2023
3 min read
Save

Novel leukemia treatment signals ‘new era in CAR T-cell therapy’

Novel leukemia treatment signals ‘new era in CAR T-cell therapy’

An investigational chimeric antigen receptor T-cell therapy demonstrated successful expansion and antitumor targeting among younger patients with advanced acute myeloid leukemia, results of the phase 1 PLAT-08 trial showed.

News
April 26, 2023
2 min read
Save

Addition of immunotherapy to chemotherapy improves survival rates of infants with leukemia

Addition of immunotherapy to chemotherapy improves survival rates of infants with leukemia

The addition of blinatumomab to Interfant-06 chemotherapy appeared safe for infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia, according to data published in The New England Journal of Medicine.

News
April 13, 2023
2 min read
Save

CV risk factor disparities in childhood cancer survivors similar to general population

CV risk factor disparities in childhood cancer survivors similar to general population

The disparate prevalence of cardiovascular risk factors among adult Black and Hispanic survivors of childhood cancer was comparable to the disparities in the American general population, researchers reported.

News
April 07, 2023
8 min watch
Save

Review highlights major advances, continuing challenges in chronic lymphocytic leukemia

Review highlights major advances, continuing challenges in chronic lymphocytic leukemia

The availability of highly effective targeted agents has changed the treatment landscape for chronic lymphocytic leukemia, but key questions about optimal strategies remain, according to a review published in JAMA.

News
February 24, 2023
3 min read
Save

Living along US-Mexico border linked to higher risk for death among children with leukemia

Living along US-Mexico border linked to higher risk for death among children with leukemia

Children with acute lymphoblastic leukemia who resided along the U.S.-Mexico border appeared at higher risk for death than their counterparts in other areas of Texas, according to study results published in Cancer.

News
February 21, 2023
4 min read
Save

Healio | HemOnc Today announces new physician leadership

Healio | HemOnc Today is excited to announce a new physician leadership structure, which features seven Associate Medical Editors from various subspecialty areas within oncology and hematology.

News
February 21, 2023
10 min read
Save

‘An opportunity for cure’ pushes cancer researcher to persevere

‘An opportunity for cure’ pushes cancer researcher to persevere

Kristen M. Hege, MD, is one of those rare individuals who excels at most of her endeavors.

News
February 16, 2023
4 min read
Save

Ponatinib ‘should be considered a standard of care’ for newly diagnosed Ph+ALL

Ponatinib ‘should be considered a standard of care’ for newly diagnosed Ph+ALL

Ponatinib conferred deeper and more durable responses than imatinib in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia who received either agent in combination with reduced-intensity chemotherapy.

News
February 03, 2023
5 min watch
Save

Inflammation levels linked to survival in acute myeloid leukemia

Inflammation levels linked to survival in acute myeloid leukemia

Severe inflammation among individuals with acute myeloid leukemia limits their bodies’ ability to kill cancerous blood cells, according to study results.

News
January 26, 2023
1 min read
Save

Breyanzi study meets complete response endpoint for leukemia, lymphoma subgroup

Breyanzi study meets complete response endpoint for leukemia, lymphoma subgroup

A phase 1/phase 2 trial of lisocabtagene maraleucel for adults with advanced chronic lymphocytic leukemia or small lymphocytic lymphoma met its primary endpoint, according to the agent’s manufacturer.

View more